NCT06711146 - Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

April 5, 2027

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

Metabolically Armed CD19 CAR-T cells

Each subject receive metabolically armed CD19 CAR- T cells by intravenous infusion

Trial Locations (1)

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou